Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval
CompanyDrug

Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval

Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy
CompanyDrug

Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy

Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness
CompanyDrug

Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness

Abbisko ABSK043 NSCLC Combo Shows 71% Disease Control at ESMO Asia
CompanyDrug

Abbisko ABSK043 NSCLC Combo Shows 71% Disease Control at ESMO Asia

Leads-Biolabs LBL-034 Multiple-Myeloma ASH Data Shows 82% ORR
CompanyDrug

Leads Biolabs LBL-034 Multiple-Myeloma ASH Data Shows 82% ORR

Junshi Biosciences roconkibart psoriasis NMPA Acceptance
CompanyDrug

Junshi Biosciences roconkibart psoriasis NMPA Acceptance

CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity
CompanyDrug

CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity

Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive
CompanyDrug

Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive

Balance-Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance
CompanyMedical Device

Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance

Shanghai Pharma X842 Deal Termination with Sinorda
CompanyDeals

Shanghai Pharma X842 Deal Termination with Sinorda

Weixikang Lidocaine-Tetracaine Cream NMPA Clinical Trial Approval
CompanyDrug

Weixikang Lidocaine-Tetracaine Cream NMPA Clinical Trial Approval

Anke-Biotech PA3-17 CAR-T Pediatric Indication NMPA Accepted
CompanyDrug

Anke-Biotech PA3-17 CAR-T Pediatric Indication NMPA Accepted